Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 518 entries
Sorted by: Best Match Show Resources per page
Interobserver concordance for endoscopic ultrasonography-guided fine-needle aspiration on-site cytopathology.

Endoscopic ultrasound

Assef M, Rossini L, Nakao F, Araki O, Bueno F, Sayeg M.
PMID: 26425515
Endosc Ultrasound. 2014 Apr;3:S15.

INTRODUCTION: Endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) is an accurate method of diagnosing and staging gastrointestinal and thoracic malignancy. A key issue in maximizing FNA accuracy is to ensure that an adequate specimen is obtained. On-site cytopathology increases the diagnostic...

Cite
Assef M, Rossini L, Nakao F, et al. Interobserver concordance for endoscopic ultrasonography-guided fine-needle aspiration on-site cytopathology. Endosc Ultrasound. 2014;3:S15
Assef, M., Rossini, L., Nakao, F., Araki, O., Bueno, F., & Sayeg, M. (2014). Interobserver concordance for endoscopic ultrasonography-guided fine-needle aspiration on-site cytopathology. Endoscopic ultrasound, 3S15.
Assef, M, et al. "Interobserver concordance for endoscopic ultrasonography-guided fine-needle aspiration on-site cytopathology." Endoscopic ultrasound vol. 3 (2014): S15.
Assef M, Rossini L, Nakao F, Araki O, Bueno F, Sayeg M. Interobserver concordance for endoscopic ultrasonography-guided fine-needle aspiration on-site cytopathology. Endosc Ultrasound. 2014 Apr;3:S15. PMID: 26425515; PMCID: PMC4569913.
Copy Download .nbib Format: NLM
Initiatives to Achieve Excellence in the Care of Acute Coronary Syndrome. Response.

Revista espanola de cardiologia (English ed.)

de Lorenzo-Pinto A, Bueno H.
PMID: 28887125
Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):1027-1028. doi: 10.1016/j.rec.2017.08.004. Epub 2017 Sep 06.

No abstract available.

Cite
de Lorenzo-Pinto A, Bueno H. Initiatives to Achieve Excellence in the Care of Acute Coronary Syndrome. Response. Rev Esp Cardiol (Engl Ed). 2017;70(11):1027-1028doi: 10.1016/j.rec.2017.08.004.
de Lorenzo-Pinto, A., & Bueno, H. (2017). Initiatives to Achieve Excellence in the Care of Acute Coronary Syndrome. Response. Revista espanola de cardiologia (English ed.), 70(11), 1027-1028. https://doi.org/10.1016/j.rec.2017.08.004
de Lorenzo-Pinto, Ana, and Bueno, Héctor. "Initiatives to Achieve Excellence in the Care of Acute Coronary Syndrome. Response." Revista espanola de cardiologia (English ed.) vol. 70,11 (2017): 1027-1028. doi: https://doi.org/10.1016/j.rec.2017.08.004
de Lorenzo-Pinto A, Bueno H. Initiatives to Achieve Excellence in the Care of Acute Coronary Syndrome. Response. Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):1027-1028. doi: 10.1016/j.rec.2017.08.004. Epub 2017 Sep 06. Spanish. PMID: 28887125.
Copy Download .nbib Format: NLM
A Potential Role of .

Frontiers in immunology

Schultz BM, Paduro CA, Salazar GA, Salazar-Echegarai FJ, Sebastián VP, Riedel CA, Kalergis AM, Alvarez-Lobos M, Bueno SM.
PMID: 28293241
Front Immunol. 2017 Feb 28;8:191. doi: 10.3389/fimmu.2017.00191. eCollection 2017.

Inflammatory bowel disease (IBD) includes a set of pathologies that result from a deregulated immune response that may affect any portion of the gastrointestinal tract. The most prevalent and defined forms of IBD are Crohn's disease and ulcerative colitis....

Cite
Schultz BM, Paduro CA, Salazar GA, et al. A Potential Role of . Front Immunol. 2017;8:191doi: 10.3389/fimmu.2017.00191.
Schultz, B. M., Paduro, C. A., Salazar, G. A., Salazar-Echegarai, F. J., Sebastián, V. P., Riedel, C. A., Kalergis, A. M., Alvarez-Lobos, M., & Bueno, S. M. (2017). A Potential Role of . Frontiers in immunology, 8191. https://doi.org/10.3389/fimmu.2017.00191
Schultz, Bárbara M, et al. "A Potential Role of ." Frontiers in immunology vol. 8 (2017): 191. doi: https://doi.org/10.3389/fimmu.2017.00191
Schultz BM, Paduro CA, Salazar GA, Salazar-Echegarai FJ, Sebastián VP, Riedel CA, Kalergis AM, Alvarez-Lobos M, Bueno SM. A Potential Role of . Front Immunol. 2017 Feb 28;8:191. doi: 10.3389/fimmu.2017.00191. eCollection 2017. PMID: 28293241; PMCID: PMC5329042.
Copy Download .nbib Format: NLM
Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation.

Frontiers in immunology

Soto L, Ferrier A, Aravena O, Fonseca E, Berendsen J, Biere A, Bueno D, Ramos V, Aguillón JC, Catalán D.
PMID: 26483788
Front Immunol. 2015 Sep 29;6:496. doi: 10.3389/fimmu.2015.00496. eCollection 2015.

The activation threshold of B cells is tightly regulated by an array of inhibitory and activator receptors in such a way that disturbances in their expression can lead to the appearance of autoimmunity. The aim of this study was...

Cite
Soto L, Ferrier A, Aravena O, et al. Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation. Front Immunol. 2015;6:496doi: 10.3389/fimmu.2015.00496.
Soto, L., Ferrier, A., Aravena, O., Fonseca, E., Berendsen, J., Biere, A., Bueno, D., Ramos, V., Aguillón, J. C., & Catalán, D. (2015). Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation. Frontiers in immunology, 6496. https://doi.org/10.3389/fimmu.2015.00496
Soto, Lilian, et al. "Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation." Frontiers in immunology vol. 6 (2015): 496. doi: https://doi.org/10.3389/fimmu.2015.00496
Soto L, Ferrier A, Aravena O, Fonseca E, Berendsen J, Biere A, Bueno D, Ramos V, Aguillón JC, Catalán D. Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation. Front Immunol. 2015 Sep 29;6:496. doi: 10.3389/fimmu.2015.00496. eCollection 2015. PMID: 26483788; PMCID: PMC4586944.
Copy Download .nbib Format: NLM
Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290.

Frontiers in endocrinology

Huang Z, Myhr C, Bathgate RA, Ho BA, Bueno A, Hu X, Xiao J, Southall N, Barnaeva E, Agoulnik IU, Marugan JJ, Ferrer M, Agoulnik AI.
PMID: 26347712
Front Endocrinol (Lausanne). 2015 Aug 17;6:128. doi: 10.3389/fendo.2015.00128. eCollection 2015.

Relaxin peptide (RLN), which signals through the relaxin family peptide 1 (RXFP1) GPCR receptor, has shown therapeutic effects in an acute heart failure clinical trial. We have identified a small-molecule agonist of human RXFP1, ML290; however, it does not...

Cite
Huang Z, Myhr C, Bathgate RA, et al. Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290. Front Endocrinol (Lausanne). 2015;6:128doi: 10.3389/fendo.2015.00128.
Huang, Z., Myhr, C., Bathgate, R. A., Ho, B. A., Bueno, A., Hu, X., Xiao, J., Southall, N., Barnaeva, E., Agoulnik, I. U., Marugan, J. J., Ferrer, M., & Agoulnik, A. I. (2015). Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290. Frontiers in endocrinology, 6128. https://doi.org/10.3389/fendo.2015.00128
Huang, Zaohua, et al. "Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290." Frontiers in endocrinology vol. 6 (2015): 128. doi: https://doi.org/10.3389/fendo.2015.00128
Huang Z, Myhr C, Bathgate RA, Ho BA, Bueno A, Hu X, Xiao J, Southall N, Barnaeva E, Agoulnik IU, Marugan JJ, Ferrer M, Agoulnik AI. Activation of Relaxin Family Receptor 1 from Different Mammalian Species by Relaxin Peptide and Small-Molecule Agonist ML290. Front Endocrinol (Lausanne). 2015 Aug 17;6:128. doi: 10.3389/fendo.2015.00128. eCollection 2015. PMID: 26347712; PMCID: PMC4538381.
Copy Download .nbib Format: NLM
A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4.

Frontiers in immunology

Retamal-Díaz AR, Kalergis AM, Bueno SM, González PA.
PMID: 28848543
Front Immunol. 2017 Aug 09;8:904. doi: 10.3389/fimmu.2017.00904. eCollection 2017.

Herpes simplex virus type 2 (HSV-2) is highly prevalent in the human population producing significant morbidity, mainly because of the generation of genital ulcers and neonatal encephalitis. Additionally, HSV-2 infection significantly increases the susceptibility of the host to acquire...

Cite
Retamal-Díaz AR, Kalergis AM, Bueno SM, et al. A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4. Front Immunol. 2017;8:904doi: 10.3389/fimmu.2017.00904.
Retamal-Díaz, A. R., Kalergis, A. M., Bueno, S. M., & González, P. A. (2017). A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4. Frontiers in immunology, 8904. https://doi.org/10.3389/fimmu.2017.00904
Retamal-Díaz, Angello R, et al. "A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4." Frontiers in immunology vol. 8 (2017): 904. doi: https://doi.org/10.3389/fimmu.2017.00904
Retamal-Díaz AR, Kalergis AM, Bueno SM, González PA. A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4. Front Immunol. 2017 Aug 09;8:904. doi: 10.3389/fimmu.2017.00904. eCollection 2017. PMID: 28848543; PMCID: PMC5553038.
Copy Download .nbib Format: NLM
Emopamil binding protein mutation in conradi-hünermann-happle syndrome representing plaque-type psoriasis.

Indian journal of dermatology

Ozyurt K, Subasioglu A, Ozturk P, Inci R, Ozkan F, Bueno E, Cañueto J, González Sarmiento R.
PMID: 25814754
Indian J Dermatol. 2015 Mar-Apr;60(2):216. doi: 10.4103/0019-5154.152570.

Conradi-Hünermann-Happle syndrome (CDPX2, OMIM 302960) is an inherited X-linked dominant variant of chondrodysplasia punctata which primarily affects the skin, bones, and eyes. CDPX2 patients display skin defects, including ichthyotic lesions, follicular atrophoderma, cicatricial alopecia, and less frequently ichthyosiform erythroderma,...

Cite
Ozyurt K, Subasioglu A, Ozturk P, et al. Emopamil binding protein mutation in conradi-hünermann-happle syndrome representing plaque-type psoriasis. Indian J Dermatol. 2015;60(2):216doi: 10.4103/0019-5154.152570.
Ozyurt, K., Subasioglu, A., Ozturk, P., Inci, R., Ozkan, F., Bueno, E., Cañueto, J., & González Sarmiento, R. (2015). Emopamil binding protein mutation in conradi-hünermann-happle syndrome representing plaque-type psoriasis. Indian journal of dermatology, 60(2), 216. https://doi.org/10.4103/0019-5154.152570
Ozyurt, Kemal, et al. "Emopamil binding protein mutation in conradi-hünermann-happle syndrome representing plaque-type psoriasis." Indian journal of dermatology vol. 60,2 (2015): 216. doi: https://doi.org/10.4103/0019-5154.152570
Ozyurt K, Subasioglu A, Ozturk P, Inci R, Ozkan F, Bueno E, Cañueto J, González Sarmiento R. Emopamil binding protein mutation in conradi-hünermann-happle syndrome representing plaque-type psoriasis. Indian J Dermatol. 2015 Mar-Apr;60(2):216. doi: 10.4103/0019-5154.152570. PMID: 25814754; PMCID: PMC4372958.
Copy Download .nbib Format: NLM
Alcohol, Brain Derived Neurotrophic Factor and Obesity among People Living with HIV.

Journal of AIDS & clinical research

Míguez-Burbano MJ, Espinoza L, Cook RL, Mayra M, Bueno D, Lewis JE, Asthana D.
PMID: 25089225
J AIDS Clin Res. 2013 Sep 20;4:245. doi: 10.4172/2155-6113.1000245.

INTRODUCTION: In an expanding HAART era, obesity has become a health problem among persons living with HIV (PLWH). Whereas the rising level of obesity has been largely attributed to poor nutrition and exercise habits, differences in biological factors may...

Cite
Míguez-Burbano MJ, Espinoza L, Cook RL, et al. Alcohol, Brain Derived Neurotrophic Factor and Obesity among People Living with HIV. J AIDS Clin Res. 2013;4:245doi: 10.4172/2155-6113.1000245.
Míguez-Burbano, M. J., Espinoza, L., Cook, R. L., Mayra, M., Bueno, D., Lewis, J. E., & Asthana, D. (2013). Alcohol, Brain Derived Neurotrophic Factor and Obesity among People Living with HIV. Journal of AIDS & clinical research, 4245. https://doi.org/10.4172/2155-6113.1000245
Míguez-Burbano, María José, et al. "Alcohol, Brain Derived Neurotrophic Factor and Obesity among People Living with HIV." Journal of AIDS & clinical research vol. 4 (2013): 245. doi: https://doi.org/10.4172/2155-6113.1000245
Míguez-Burbano MJ, Espinoza L, Cook RL, Mayra M, Bueno D, Lewis JE, Asthana D. Alcohol, Brain Derived Neurotrophic Factor and Obesity among People Living with HIV. J AIDS Clin Res. 2013 Sep 20;4:245. doi: 10.4172/2155-6113.1000245. PMID: 25089225; PMCID: PMC4117393.
Copy Download .nbib Format: NLM
Dearomatization of Antioxidant Rosemary Extracts by Treatment with Supercritical Carbon Dioxide.

Journal of agricultural and food chemistry

López-Sebastián S, Ramos E, Ibáñez E, Bueno JM, Ballester L, Tabera J, Reglero G.
PMID: 10554189
J Agric Food Chem. 1998 Jan 19;46(1):13-19. doi: 10.1021/jf970565n.

Treatment with supercritical CO(2) is proposed for deodorizing antioxidant rosemary extracts obtained by steam distillation and Soxhlet extraction. The process conditions have been optimized by applying a Taguchi experimental design with the aim of obtaining, at minimum cost, a...

Cite
López-Sebastián S, Ramos E, Ibáñez E, et al. Dearomatization of Antioxidant Rosemary Extracts by Treatment with Supercritical Carbon Dioxide. J Agric Food Chem. 1998;46(1):13-19doi: 10.1021/jf970565n.
López-Sebastián, S., Ramos, E., Ibáñez, E., Bueno, J. M., Ballester, L., Tabera, J., & Reglero, G. (1998). Dearomatization of Antioxidant Rosemary Extracts by Treatment with Supercritical Carbon Dioxide. Journal of agricultural and food chemistry, 46(1), 13-19. https://doi.org/10.1021/jf970565n
López-Sebastián, et al. "Dearomatization of Antioxidant Rosemary Extracts by Treatment with Supercritical Carbon Dioxide." Journal of agricultural and food chemistry vol. 46,1 (1998): 13-19. doi: https://doi.org/10.1021/jf970565n
López-Sebastián S, Ramos E, Ibáñez E, Bueno JM, Ballester L, Tabera J, Reglero G. Dearomatization of Antioxidant Rosemary Extracts by Treatment with Supercritical Carbon Dioxide. J Agric Food Chem. 1998 Jan 19;46(1):13-19. doi: 10.1021/jf970565n. PMID: 10554189.
Copy Download .nbib Format: NLM
A Proton-Ionizable Ester Crown of 3,5-Disubstituted 1H-Pyrazole Able To Form Stable Dinuclear Complexes with Lipophilic Phenethylamines.

The Journal of organic chemistry

Campayo L, Bueno JM, Navarro P, Ochoa C, Jimenez-Barbero J, Pèpe G, Samat A.
PMID: 11671626
J Org Chem. 1997 May 02;62(9):2684-2693. doi: 10.1021/jo9623651.

A convenient synthesis of the proton-ionizable crown 3 is reported that uses dibutyltin oxide. In acetonitrile, the reaction of 3 (LH(2)) with phenethylamine and homoveratrylamine (molar ratio 1:2) affords solid dinuclear complexes [LH(2)]2RNH(2) (4a,b), which spectroscopic (FAB-MS, IR, (1)H...

Cite
Campayo L, Bueno JM, Navarro P, et al. A Proton-Ionizable Ester Crown of 3,5-Disubstituted 1H-Pyrazole Able To Form Stable Dinuclear Complexes with Lipophilic Phenethylamines. J Org Chem. 1997;62(9):2684-2693doi: 10.1021/jo9623651.
Campayo, L., Bueno, J. M., Navarro, P., Ochoa, C., Jimenez-Barbero, J., Pèpe, G., & Samat, A. (1997). A Proton-Ionizable Ester Crown of 3,5-Disubstituted 1H-Pyrazole Able To Form Stable Dinuclear Complexes with Lipophilic Phenethylamines. The Journal of organic chemistry, 62(9), 2684-2693. https://doi.org/10.1021/jo9623651
Campayo, Lucrecia, et al. "A Proton-Ionizable Ester Crown of 3,5-Disubstituted 1H-Pyrazole Able To Form Stable Dinuclear Complexes with Lipophilic Phenethylamines." The Journal of organic chemistry vol. 62,9 (1997): 2684-2693. doi: https://doi.org/10.1021/jo9623651
Campayo L, Bueno JM, Navarro P, Ochoa C, Jimenez-Barbero J, Pèpe G, Samat A. A Proton-Ionizable Ester Crown of 3,5-Disubstituted 1H-Pyrazole Able To Form Stable Dinuclear Complexes with Lipophilic Phenethylamines. J Org Chem. 1997 May 02;62(9):2684-2693. doi: 10.1021/jo9623651. PMID: 11671626.
Copy Download .nbib Format: NLM
[LIVER CANCER IN HYPERENDEMIC AREA OF B AND DELTAHEPATITIS: REPORT OF 19 CASES].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru

Indacochea S, Bueno R, De La Fuente J, Ferrufino JC.
PMID: 12221437
Rev Gastroenterol Peru. 1997 Jan-Apr;17(1):56-59.

This is a prospective study that includes 19 hospitalized patients with hepatic cancer at the Medicine Department of the Regional Hospital in Cuzco (Perú), between August 1992 to August 1995. Epidemiological and clinical information was obtained from all patients....

Cite
Indacochea S, Bueno R, De La Fuente J, et al. Cáncer Hepático en AreaEndémica de Hepatitis B y Delta B: A propósito de 19 casos. [LIVER CANCER IN HYPERENDEMIC AREA OF B AND DELTAHEPATITIS: REPORT OF 19 CASES]. Rev Gastroenterol Peru. 1997;17(1):56-59
Indacochea, S., Bueno, R., De La Fuente, J., & Ferrufino, J. C. (1997). Cáncer Hepático en AreaEndémica de Hepatitis B y Delta B: A propósito de 19 casos. [LIVER CANCER IN HYPERENDEMIC AREA OF B AND DELTAHEPATITIS: REPORT OF 19 CASES]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, 17(1), 56-59.
Indacochea, Sonia, et al. "Cáncer Hepático en AreaEndémica de Hepatitis B y Delta B: A propósito de 19 casos." [LIVER CANCER IN HYPERENDEMIC AREA OF B AND DELTAHEPATITIS: REPORT OF 19 CASES]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru vol. 17,1 (1997): 56-59.
Indacochea S, Bueno R, De La Fuente J, Ferrufino JC. Cáncer Hepático en AreaEndémica de Hepatitis B y Delta B: A propósito de 19 casos. [LIVER CANCER IN HYPERENDEMIC AREA OF B AND DELTAHEPATITIS: REPORT OF 19 CASES]. Rev Gastroenterol Peru. 1997 Jan-Apr;17(1):56-59. Spanish. PMID: 12221437.
Copy Download .nbib Format: NLM
The molecular and supramolecular structures of the isomeric compounds 5,7-dimethoxyimidazo[1,2-c]pyrimidine and 7-methoxy-1-methylimidazo[1,2-a]pyrimidin-5(1H)-one.

Acta crystallographica. Section C, Crystal structure communications

Bueno J, Melguizo M, Quijano ML, Low JN.
PMID: 12855857
Acta Crystallogr C. 2003 Jul;59:o363-6. doi: 10.1107/s0108270103010266. Epub 2003 Jun 11.

The supramolecular structures of the isomeric compounds 5,7-dimethoxyimidazo[1,2-c]pyrimidine, C(8)H(9)N(3)O(2), (I), and 7-methoxy-1-methylimidazo[1,2-a]pyrimidin-5(1H)-one, C(8)H(9)N(3)O(2), (II), are determined by weak C-H.N and C-H.O hydrogen bonds in (I), which generate alternating linked centrosymmetric R(2)(2)(8) and R(2)(2)(10) rings that form a ribbon running...

Cite
Bueno J, Melguizo M, Quijano ML, et al. The molecular and supramolecular structures of the isomeric compounds 5,7-dimethoxyimidazo[1,2-c]pyrimidine and 7-methoxy-1-methylimidazo[1,2-a]pyrimidin-5(1H)-one. Acta Crystallogr C. 2003;59:o363-6doi: 10.1107/s0108270103010266.
Bueno, J., Melguizo, M., Quijano, M. L., & Low, J. N. (2003). The molecular and supramolecular structures of the isomeric compounds 5,7-dimethoxyimidazo[1,2-c]pyrimidine and 7-methoxy-1-methylimidazo[1,2-a]pyrimidin-5(1H)-one. Acta crystallographica. Section C, Crystal structure communications, 59o363-6. https://doi.org/10.1107/s0108270103010266
Bueno, Jesus, et al. "The molecular and supramolecular structures of the isomeric compounds 5,7-dimethoxyimidazo[1,2-c]pyrimidine and 7-methoxy-1-methylimidazo[1,2-a]pyrimidin-5(1H)-one." Acta crystallographica. Section C, Crystal structure communications vol. 59 (2003): o363-6. doi: https://doi.org/10.1107/s0108270103010266
Bueno J, Melguizo M, Quijano ML, Low JN. The molecular and supramolecular structures of the isomeric compounds 5,7-dimethoxyimidazo[1,2-c]pyrimidine and 7-methoxy-1-methylimidazo[1,2-a]pyrimidin-5(1H)-one. Acta Crystallogr C. 2003 Jul;59:o363-6. doi: 10.1107/s0108270103010266. Epub 2003 Jun 11. PMID: 12855857.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 518 entries